Lek gets EUR 7m incentive for EUR 70m investment
Ljubljana/Prevalje, 29 December - The Ministry for Economic Development and Technology and pharmaceutical company Lek, a subsidiary of Swiss giant Novartis, have signed a contract for a EUR 7m incentive as the company plans to expand its factory in Prevalje (N), an investment worth EUR 70m.
The rest of this news item is available to subscribers.
The news item consists of 1.267 characters (without spaces) or 260 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.